
Saturday, October 26, 2024 2:17:46 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent DNLI News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/09/2025 08:13:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2025 12:04:57 PM
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II) • GlobeNewswire Inc. • 07/07/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2025 08:34:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2025 08:25:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2025 08:05:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2025 08:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 08:03:05 PM
- Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome • GlobeNewswire Inc. • 05/06/2025 08:01:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/17/2025 08:07:55 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/17/2025 08:06:10 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/17/2025 08:05:24 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/17/2025 07:05:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2025 12:02:58 PM
- Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program • GlobeNewswire Inc. • 04/02/2025 12:00:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2025 10:26:35 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2025 09:13:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2025 09:12:41 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 02/27/2025 09:11:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2025 09:05:58 PM
- Denali Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 02/27/2025 09:01:00 PM
- Denali Therapeutics Announces Primary Analysis and Long-Term Follow-Up of Phase 1/2 Study in Hunter Syndrome (MPS II) with Tividenofusp Alfa • GlobeNewswire Inc. • 02/06/2025 04:42:00 PM
- Denali Therapeutics Announces Upcoming Presentations on Hunter Syndrome (MPS II) and TransportVehicle™ Enabled Investigational Therapeutic Tividenofusp Alfa at the 2025 WORLDSymposium™ • GlobeNewswire Inc. • 01/30/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:03:25 PM
- Denali Therapeutics Announces Key Anticipated 2025 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases • GlobeNewswire Inc. • 01/13/2025 01:00:00 PM
FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM